Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD
NCT02887859
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Artery Disease
Interventions
BIOLOGICAL:
Human Acellular Vessel (HAV)
Sponsor
Humacyte, Inc.
Collaborators
[object Object]